Axonal regeneration and sprouting as a potential therapeutic target for nervous system disorders

被引:30
作者
Marshall, Katherine L. [1 ]
Farah, Mohamed H. [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA
关键词
amyotrophic lateral sclerosis; axonal regeneration; dying-back axonopathy; in vitro neuromuscular junction; iPSC-derived motor neurons; microfluidic device; motor axon sprouting; AMYOTROPHIC-LATERAL-SCLEROSIS; TERMINAL SCHWANN-CELLS; PLACEBO-CONTROLLED TRIAL; NEUROMUSCULAR-JUNCTION; SKELETAL-MUSCLE; MOTOR-NEURONS; SPINAL-CORD; MOUSE MODEL; MOLECULAR-MECHANISMS; HUNTINGTONS-DISEASE;
D O I
10.4103/1673-5374.308077
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Nervous system disorders are prevalent health issues that will only continue to increase in frequency as the population ages. Dying-back axonopathy is a hallmark of many neurologic diseases and leads to axonal disconnection from their targets, which in turn leads to functional impairment. During the course of many of neurologic diseases, axons can regenerate or sprout in an attempt to reconnect with the target and restore synapse function. In amyotrophic lateral sclerosis (ALS), distal motor axons retract from neuromuscular junctions early in the disease-course before significant motor neuron death. There is evidence of compensatory motor axon sprouting and reinnervation of neuromuscular junctions in ALS that is usually quickly overtaken by the disease course. Potential drugs that enhance compensatory sprouting and encourage reinnervation may slow symptom progression and retain muscle function for a longer period of time in ALS and in other diseases that exhibit dying-back axonopathy. There remain many outstanding questions as to the impact of distinct disease-causing mutations on axonal outgrowth and regeneration, especially in regards to motor neurons derived from patient induced pluripotent stem cells. Compartmentalized microfluidic chambers are powerful tools for studying the distal axons of human induced pluripotent stem cells-derived motor neurons, and have recently been used to demonstrate striking regeneration defects in human motor neurons harboring ALS disease-causing mutations. Modeling the human neuromuscular circuit with human induced pluripotent stem cells-derived motor neurons will be critical for developing drugs that enhance axonal regeneration, sprouting, and reinnervation of neuromuscular junctions. In this review we will discuss compensatory axonal sprouting as a potential therapeutic target for ALS, and the use of compartmentalized microfluidic devices to find drugs that enhance regeneration and axonal sprouting of motor axons.
引用
收藏
页码:1901 / 1910
页数:10
相关论文
共 175 条
  • [71] LOCAL RE-INNERVATION IN PARTIALLY DENERVATED MUSCLE - A HISTO-PHYSIOLOGICAL STUDY
    HOFFMAN, H
    [J]. AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE, 1950, 28 (04): : 383 - 397
  • [72] Schwann cells express motor and sensory phenotypes that regulate axon regeneration
    Hoke, A.
    Redett, R.
    Hameed, H.
    Jari, R.
    Zhou, C.
    Li, Z. B.
    Griffin, J. W.
    Brushart, T. M.
    [J]. JOURNAL OF NEUROSCIENCE, 2006, 26 (38) : 9646 - 9655
  • [73] In vivo evidence for reduced ion channel expression in motor axons of patients with amyotrophic lateral sclerosis
    Howells, James
    Matamala, Jose Manuel
    Park, Susanna B.
    Garg, Nidhi
    Vucic, Steve
    Bostock, Hugh
    Burke, David
    Kiernan, Matthew C.
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2018, 596 (22): : 5379 - 5396
  • [74] Investigational BACE inhibitors for the treatment of Alzheimer's disease
    Imbimbo, Bruno P.
    Watling, Mark
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (11) : 967 - 975
  • [75] Compartmental microfluidic system for studying muscle-neuron communication and neuromuscular junction maintenance
    Ionescu, Ariel
    Zahavi, Eitan Erez
    Gradus, Tal
    Ben-Yaakov, Keren
    Perlson, Eran
    [J]. EUROPEAN JOURNAL OF CELL BIOLOGY, 2016, 95 (02) : 69 - 88
  • [76] James SL, 2019, LANCET NEUROL, V18, P56, DOI [10.1016/S1474-4422(18)30499-X, 10.1016/S1474-4422(18)30415-0, 10.1016/S1474-4422(19)30034-1]
  • [77] Skeletal Muscle Remodelling as a Function of Disease Progression in Amyotrophic Lateral Sclerosis
    Jensen, L.
    Jorgensen, L. H.
    Bech, R. D.
    Frandsen, U.
    Schroder, H. D.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [78] Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity
    Jokic, N
    de Aguilar, JLG
    Pradat, PF
    Dupuis, L
    Echaniz-Laguna, A
    Muller, A
    Dubourg, O
    Seilhean, D
    Hauw, JJ
    Loeffler, JP
    Meininger, V
    [J]. ANNALS OF NEUROLOGY, 2005, 57 (04) : 553 - 556
  • [79] Cellular and Molecular Anatomy of the Human Neuromuscular Junction
    Jones, Ross A.
    Harrison, Carl
    Eaton, Samantha L.
    Hurtado, Maica Llavero
    Graham, Laura C.
    Alkhammash, Leena
    Oladiran, Oladayo A.
    Gale, Andy
    Lamont, Douglas J.
    Simpson, Hamish
    Simmen, Martin W.
    Soeller, Christian
    Wishart, Thomas M.
    Gillingwater, Thomas H.
    [J]. CELL REPORTS, 2017, 21 (09): : 2348 - 2356
  • [80] ROCK inhibition improves axonal regeneration in a preclinical model of amyotrophic lateral sclerosis
    Joshi, Abhijeet R.
    Muke, Ines
    Bobylev, Ilja
    Lehman, Helmar C.
    [J]. JOURNAL OF COMPARATIVE NEUROLOGY, 2019, 527 (14) : 2334 - 2340